VF
LXRX icon

Virtu Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Virtu Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,468
Closed -$42K – 2024
2025
Q4 		$42K Buy
+36,468
New +$50.1K ﹤0.01% 1328
2025
Q3 		– Sell
-146,805
Closed -$139K – 1826
2025
Q2 		$139K Buy
+146,805
New +$95.1K 0.01% 986
2025
Q1 		– Sell
-88,982
Closed -$66K – 1743
2024
Q4 		$66K Buy
+88,982
New +$107K ﹤0.01% 1109
2024
Q2 		– Sell
-43,591
Closed -$105K – 1639
2024
Q1 		$105K Buy
+43,591
New +$93.6K 0.01% 918
2023
Q3 		– Sell
-19,948
Closed -$46K – 1637
2023
Q2 		$46K Sell
19,948
-1,781
-8% -$4.73K ﹤0.01% 1148
2023
Q1 		$53K Buy
+21,729
New +$49.8K 0.01% 1084
2022
Q4 		– Sell
-13,458
Closed -$32K – 1936
2022
Q3 		$32K Buy
+13,458
New +$37.2K ﹤0.01% 1301
2020
Q3 		– Sell
-69,282
Closed -$138K – 1324
2020
Q2 		$138K Buy
+69,282
New +$136K 0.02% 806
2019
Q2 		– Sell
-35,164
Closed -$196K – 1684
2019
Q1 		$196K Buy
+35,164
New +$214K 0.01% 1017
2017
Q4 		– Sell
-11,993
Closed -$147K – 2726
2017
Q3 		$147K Buy
+11,993
New +$177K 0.01% 1970
2014
Q2 		– Sell
-2,398
Closed -$29K – 397
2014
Q1 		$29K Buy
+2,398
New +$30.6K ﹤0.01% 384

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial's LXRX Position: Q1 2026 in Review

Virtu Financial sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 36,468 shares — an estimated $42K sold.

Virtu Financial first reported a position in LXRX in Q1 2014 and held it in 11 quarters. The position peaked at $196K in Q1 2019. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Virtu Financial reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 36,468 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $42K.
  • Virtu Financial first reported a position in Lexicon Pharmaceuticals in Q1 2014 and held it in 11 quarters.
  • Virtu Financial's Lexicon Pharmaceuticals position peaked at $196K in Q1 2019.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.